University of Maryland School of Medicine,

Department of Radiation Oncology
655 West Baltimore Street
Baltimore, Maryland 21201
Phone: 410.328.2326
Fax: 410.706.0467
Email Address: wregine@umm.edu
Click Here To Visit Website

The University of Maryland School of Medicine (UMSC) is the nation's first public medical school, it is the fifth oldest, and it is the first U.S. medical school to institute a residency training program. Established in 1807, the School of Medicine is the founding school of the University of Maryland. As the founding school, the medical school is the lifeblood of the University of Maryland’s 11 campuses. This academic center trains physicians, researchers, and other medical professionals to enter the University of Maryland medical system, which combines biomedical research, medical education, patient care, and community service. UMSC is also a prominent leader in biomedical research and medical education.

The University of Maryland School of Medicine consists of roughly 25 departments, six research centers, two institutes, nearly two dozen Graduate and Ph.D. programs, and several medical programs including: Comparative Medicine, Complimentary Medicine, Genetics & Genomic Medicine, Minority Health & Health Disparities, Neuroscience, Trauma, and Oncology. Directed by Kevin M. Cullen, the Program in Oncology, of the University of Maryland Greenebaum Cancer Center (UMGCC), faculty members attend services on medical oncology and hematology as well as participate in multidisciplinary clinical programs centered around specific cancers (thoracic, breast, thoracic, genitourinary, gynecologic, head and neck, gastroenterologic, and hematologic malignancies) with specialists from medical, surgical, and radiation oncology to provide integrated care for each cancer patient.

The Department of Radiation Oncology at UMSC ranks sixth in the nation for research and funding. Led by Department Chair Dr. William F. Regine, the Department of Radiation Oncology is devoted to the treatment of benign and malignant tumors. Under the direction of Dr. Regina, the department utilizes the best possible treatment for -- mulit-modality therapy. Multi-modality therapy offers a patient the greatest chance of survival, and it requires a multi-disciplinary approach to the evaluation and treatment of the disease. Currently, fifty percent of all patients being treated in the Department of Radiation Oncology are being treated for a cure, and approximately 30 percent of patients treated for a cure are being treated with radiation therapy as a sole method of treatment and as the method of choice to achieve a cure.

Dr. William F. Regine is also Professor of Radiation Oncology. His interests include the study and treatment of pancreas and gastrointestinal cancers, brain tumors, and head and neck cancers. Dr. Regine is also currently working on an innovative drug delivery service for the treatment of brain tumors.